(294 days)
Not Found
Not Found
No
The summary explicitly states "Mentions AI, DNN, or ML: Not Found" and the device description focuses on traditional signal processing techniques (acquire, amplify, filter, record, analyze).
No
The device is described as being for "analysis, interpretation and documentation of lung sounds" and "to perform an acoustic pulmonary function measurement that quantifies the presence of wheezing," and "to listen to amplified and filtered breath sounds." This indicates a diagnostic or monitoring purpose, not a therapeutic one.
Yes
This device is intended for the "analysis, interpretation and documentation of lung sounds" and "quantifies the presence of wheezing," which are activities that help a physician make a diagnosis.
No
The device description explicitly states it is a "computer based electronic stethoscope that utilizes up to five contact sensors simultaneously to acquire, amplify, filter, record and analyze pulmonary sounds," indicating the presence of hardware components (sensors, computer, etc.) beyond just software.
Based on the provided information, the PulmoTrack Model 1010 is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- PulmoTrack's Function: The PulmoTrack Model 1010 analyzes and interprets lung sounds acquired through contact sensors placed on the trachea and thorax. This is a non-invasive method of collecting data directly from the body, not from a sample taken from the body.
- Intended Use: The intended use describes the analysis of lung sounds during physical examinations and pulmonary function testing, which are clinical procedures performed on the patient directly.
Therefore, the PulmoTrack Model 1010 falls under the category of a medical device used for in vivo (within the living body) analysis, not in vitro (in glass/outside the living body) diagnostics.
N/A
Intended Use / Indications for Use
The PulmoTrack Model 1010 is intended for the analysis, interpretation and documentation of lung sounds.
The PulmoTrack Model 1010 is indicated for use by or under the supervision of a physician while carrying out a provocation test, administering a bronchodilator or performing a physical examination in a pulmonary function testing environment when there is a need to perform an acoustic pulmonary function measurement that quantifies the presence of wheezing. It is also indicated when there is a need to listen to amplified and filtered breath sounds.
Product codes
73 BZM
Device Description
The PulmoTrack is a computer based electronic stethoscope that utilizes up to five contact sensors simultaneously to acquire, amplify, filter, record and analyze pulmonary sounds from the trachea and thorax and provides high fidelity audio outputs, visual displays and printed reports.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
lungs, trachea, thorax
Indicated Patient Age Range
Not Found
Intended User / Care Setting
physician, pulmonary function testing environment
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Not Found
Key Metrics
Not Found
Predicate Device(s)
The PulmoTrack Model 1010 is substantially equivalent to the combination of the Littmann Brand Electronic Stethoscope and the Pulmonary Function Test Laboratory, System1010.
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 868.1900 Diagnostic pulmonary-function interpretation calculator.
(a)
Identification. A diagnostic pulmonary-function interpretation calculator is a device that interprets pulmonary study data to determine clinical significance of pulmonary-function values.(b)
Classification. Class II (performance standards).
0
IV. SUMMARY OF SAFETY AND EFFECTIVENESS
This summary of safety and effectiveness information is being submitted in accordance with the requirements of the SMDA 1990 and 21 CFR 807.92.
Submitter:
Karmel Medical Acoustic Technologies Ltd., POB 389, Tirat Hacarmel,39554, Israel
Tel: +972-4-857-4424 Fax: +972-4-857-7008
Name of the Device: PulmoTrack Model 1010
Predicate Devices: The PulmoTrack Model 1010 is substantially equivalent to the combination of the Littmann Brand Electronic Stethoscope and the Pulmonary Function Test Laboratory, System1010.
Description of the Device:
The PulmoTrack is a computer based electronic stethoscope that utilizes up to five contact sensors simultaneously to acquire, amplify, filter, record and analyze pulmonary sounds from the trachea and thorax and provides high fidelity audio outputs, visual displays and printed reports.
1
Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the top half of the circle. Inside the circle is an abstract symbol that resembles a stylized caduceus or a family of three people.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
DEC 28 1998
Dr. Charles S. Irving Karmel Medical Acoustic Technologies Ltd. 9 Ezel Street, P.O. Box 389 Tirat Hacarmel ISRAEL 39554
Re: K980878 PulmoTrack™ Model 1010 Regulatory Class: II (two) Product Code: 73 BZM October 28, 1998 Dated: Received: October 29, 1998
Dear Dr. Irving:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to leqally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
2
Page 2 - Dr. Charles S. Irving
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other qeneral information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours,
Thomas J. Callahan, Ph.D.
Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
INDICATIONS FOR USE
| 510(k) Number (if known): | K980878 |
|---|---|
| --------------------------- | --------- |
Device Name:
PulmoTrack™ Model 1010
Indications For Use:
The PulmoTrack Model 1010 is intended for the analysis, interpretation and documentation of lung sounds.
The PulmoTrack Model 1010 is indicated for use by or under the supervision of a physician while carrying out a provocation test, administering a bronchodilator or performing a physical examination in a pulmonary function testing environment when there is a need to perform an acoustic pulmonary function measurement that quantifies the presence of wheezing. It is also indicated when there is a need to listen to amplified and filtered breath sounds.
(PLEASE DO NOT WRITE BELOW THIS LINE -CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)
Marla Kramer
(Division Sign-Off) Division of Cardiovascular, Respiratory, and Neurological Devices
510(k) Number R920876
Prescription Use (Per 21 CFR 801.109)
OR
Over the Counter Use